Thiamine deficiency and recovery: impact of recurrent episodes and beneficial effect of treatment with Trolox and dimethyl sulfoxide
- 1 September 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 394 (11), 2289-2307
- https://doi.org/10.1007/s00210-021-02148-5
Abstract
At present, thiamine deficiency (TD) is managed with administration of high doses of thiamine. Even so, severe and permanent neurological disorders can occur in recurrent episodes of TD. In this study, we used a murine model to assess the efficacy of TD recovery treatments using thiamine with or without additional administration of the antioxidant Trolox or the anti-inflammatory dimethyl sulfoxide (DMSO) after a single or recurrent episode of TD. TD was induced for 9 days with deficient chow and pyrithiamine, and the recovery period was 7 days with standard amounts of chow and thiamine, Trolox, and/or DMSO. After these periods, we evaluated behavior, histopathology, and ERK1/2 modulation in the brain. Deficient animals showed reductions in locomotor activity, motor coordination, and spatial memory. Morphologically, after a single episode of TD and recovery, deficient mice showed neuronal vacuolization in the dorsal thalamus and, after two episodes, a reduction in neuronal cell number. These effects were attenuated or reversed by the recovery treatments, mainly in the treatments with thiamine associated with Trolox or DMSO. Deficient animals showed a strong increase in ERK1/2 phosphorylation in the thalamus, hippocampus, and cerebral cortex after one deficiency episode and recovery. Interestingly, after recurrent TD and recovery, ERK1/2 phosphorylation remained high only in the deficient mice treated with thiamine and/or Trolox or thiamine with DMSO. Our data suggest that a protocol for TD treatment with thiamine in conjunction with Trolox or DMSO enhances the recovery of animals and possibly minimizes the late neurological sequelae.Keywords
Funding Information
- Fundação de Amparo á Pesquisa do Estado do Tocantins (837598/2016)
This publication has 84 references indexed in Scilit:
- Thiamine Deficiency Induced Neurochemical, Neuroanatomical, and Neuropsychological Alterations: A ReappraisalThe Scientific World Journal, 2013
- In Vivo Manganese Exposure Modulates Erk, Akt and Darpp-32 in the Striatum of Developing Rats, and Impairs Their Motor FunctionPLOS ONE, 2012
- Brain and behavioral pathology in an animal model of Wernicke's encephalopathy and Wernicke–Korsakoff SyndromeBrain Research, 2012
- Microglial activation is a major contributor to neurologic dysfunction in thiamine deficiencyBiochemical and Biophysical Research Communications, 2010
- The Akt signaling pathway contributes to postconditioning’s protection against stroke; the protection is associated with the MAPK and PKC pathwaysJournal of Neurochemistry, 2008
- Thiamine deficiency decreases glutamate uptake in the prefrontal cortex and impairs spatial memory performance in a water maze testPharmacology Biochemistry and Behavior, 2006
- Congenital hypothyroidism alters the phosphorylation of ERK1/2 and p38MAPK in the hippocampus of neonatal ratsDevelopmental Brain Research, 2005
- Neuropathology of thiamine deficiency disordersMetabolic Brain Disease, 1996
- Pathogenesis of diencephalic lesions in an experimental model of Wernicke's encephalopathyMetabolic Brain Disease, 1995
- Recovery of Postischemic Brain Metabolism and Function Following Treatment with a Free Radical Scavenger and Platelet-Activating Factor AntagonistsJournal of Neurochemistry, 1991